These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1139592

  • 1. [The hepatotoxic action of erythromycin (author's transl)].
    Svejda J, Richter J.
    Cas Lek Cesk; 1975 Mar 28; 114(13):407-10. PubMed ID: 1139592
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Controlled study of the liver-protective effect of cycloxilic acid in a form of iatrogenic liver disease].
    Neuman M, Fluteau G.
    Clin Ter; 1978 Nov 15; 87(3):243-64. PubMed ID: 380876
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of erythromycin ethyl succinate, stearate and estolate treatments of group A streptococcal infections of the upper respiratory tract.
    Janicki RS, Garnham JC, Worland MC, Grundy WE, Thomas JR.
    Clin Pediatr (Phila); 1975 Dec 15; 14(12):1098-107. PubMed ID: 1104241
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythromycin estolate-induced hepatitis. Ultrastructural study of liver.
    Gafter U, Mandel EM, Weiss S, Djaldetti M.
    N Y State J Med; 1979 Jan 15; 79(1):87-9. PubMed ID: 282477
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Surgical and drug treatment of infection of the extremities].
    Marques EF.
    Hospital (Rio J); 1969 Jun 15; 75(6):2099-106. PubMed ID: 5311465
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical effects of erythrocin for the infectious diseases of the mouth].
    Suzuki S, Noshiro T, Kuga Y, Fukuda J, Hida J.
    Shikai Tenbo; 1978 Jun 15; 52(3):533-9. PubMed ID: 295915
    [No Abstract] [Full Text] [Related]

  • 18. The usefulness of erythromycin in paediatrics.
    Gołeebiowska H, Prokopczyk J, Pawluch D, Nowakowska K, Bozkowa K.
    J Chemother; 1989 Jul 15; 1(4 Suppl):689-90. PubMed ID: 16312594
    [No Abstract] [Full Text] [Related]

  • 19. A study of erythromycin activity in vivo.
    Gomez Lus R, Rubio Calvo MC, Davis PE, Larrad L, Gomez G, Guillen Agudo G, Blay V.
    J Int Med Res; 1980 Jul 15; 8 Suppl 2():24-35. PubMed ID: 7429003
    [No Abstract] [Full Text] [Related]

  • 20. A prospective study on the incidence of liver function abnormalities in children receiving erythromycin estolate, erythromycin ethylsuccinate or penicillin V for treatment of pneumonia.
    Ginsburg CM.
    Pediatr Infect Dis; 1986 Jul 15; 5(1):151-3. PubMed ID: 3080735
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.